About Abyss Pharma Private Limited
Data last updated:
Abyss Pharma Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 03 June 1997 and has been in existence for over 29 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24232DL1997PTC087663. Its GSTIN is 07AABCA8551E2ZU (Delhi). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹9.95 Lakh. It is led by directors Nitin Gupta and Vimal Kumar Gupta.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at B – 121 Phase – I Mayapuri Industrial Area, New Delhi, Delhi, India – 110064.
As per the financials filed for FY 2024, the company reported a revenue of ₹19.15 Cr, a growth of 7% compared to the previous year. For the same year it recorded a net profit of ₹34.05 Lakh (net margin 1.8%) and EBITDA of ₹82.69 Lakh (EBITDA margin 4.3%). Revenue has grown at a compounded annual rate (CAGR) of 13% over three years and 30% over five years.
The company has about 19 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Abyss Pharma. As per MCA filings, the company has open charges of ₹50.77 Lakh on record. Court records list 4 cases involving the company, including 2 filed by the company and 2 filed against it; 1 case is pending.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website abysspharma.com.
- EmailLocked
- TelephoneLocked
- Website
- Social Media
- Registered AddressB – 121 Phase – I Mayapuri Industrial Area, New Delhi, Delhi, India – 110064
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Abyss Pharma Private Limited
The main business activity of Abyss Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Abyss Pharma Private Limited FY 2025 filings available
Abyss Pharma Private Limited reported revenue of ₹19.15 Cr (up 7% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR) of Abyss Pharma Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 30% over five years, including 7% growth in the latest year. EBITDA rose 29% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Abyss Pharma Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | ₹19.15 Cr | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹82.69 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹34.05 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Abyss Pharma Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 4.3% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 1.8% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Abyss Pharma are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Abyss Pharma Private Limited
Abyss Pharma Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Formulations). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Curosis Healthcare Private Limited | ₹19.23 Cr (FY 2024) | •••• | •••• | 16.0% | •••• | Ahmedabad, Gujarat, India |
| Elkos Healthcare Private Limited | ₹19.21 Cr (FY 2025) | •••• | •••• | 10.0% | •••• | Shahabad Markanda, Haryana, India |
| Invex Health Private Limited | ₹19.2 Cr (FY 2025) | •••• | •••• | -58.0% | •••• | Neemuch, Madhya Pradesh, India |
| Dr.Jrk's Research and Pharmaceuticals Private Limited | ₹19.15 Cr (FY 2025) | •••• | •••• | 4.0% | •••• | Chennai, Tamil Nadu, India |
| Elegant Cosmed Private Limited | ₹19.15 Cr (FY 2024) | •••• | •••• | 27.0% | •••• | Rajkot, Gujarat, India |
| Abyss Pharma Private Limited this company | ₹19.15 Cr (FY 2024) | •••• | •••• | 7.0% | •••• | New Delhi, Delhi, India |
| Croient Pharma Private Limited | ₹19.13 Cr (FY 2024) | •••• | •••• | 76.0% | •••• | Thane, Maharashtra, India |
| Jinay Pharmaceuticals Private Limited | ₹19.11 Cr (FY 2024) | •••• | •••• | 121.0% | •••• | Thane, Maharashtra, India |
| Srinija Drugs Private Limited | ₹19.09 Cr (FY 2024) | •••• | •••• | 64.0% | •••• | Andhra Pradesh, India |
| Omega Biotech Limited | ₹19.07 Cr (FY 2024) | •••• | •••• | 10.0% | •••• | New Delhi, Delhi, India |
| Maha Avtar Health Care Private Limited | ₹19.06 Cr (FY 2025) | •••• | •••• | 43.0% | •••• | Delhi, India |
Peers are the five companies nearest above and the five nearest below Abyss Pharma by revenue in the Pharma industry (Formulations), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Abyss Pharma Private Limited
Abyss Pharma Private Limited is audited by MAHESH YADAV & ASSOCAITES for the financial year 2024.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| MAHESH YADAV & ASSOCAITES | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Abyss Pharma Private Limited
Abyss Pharma has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Nitin Gupta | Director | 30 Nov 2022 | 3 Years 10 Months | Current |
| Vimal Kumar Gupta Also directs: Sunrise Heritage LLP, Star Imaging and Path Lab Limited | Director | 03 Jun 1997 | 29 Years 4 Months | Current |
Ownership and Shareholding of Abyss Pharma Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Abyss Pharma Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 20 Nov 2023 | Hdfc Bank Limited | ₹15 Lakh | Open |
| 16 Nov 2021 | Others | ₹35.77 Lakh | Open |
Total charge records: 2 View all charges
Legal Cases of Abyss Pharma Private Limited
Abyss Pharma Private Limited has 4 court cases on record: 2 filed by Abyss Pharma, 2 filed against it. 1 case is pending and 3 are disposed. Status as checked between 30 Sep 2026 and 04 Oct 2026.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 2 | 0 | 0 |
| District courts | 2 | 2 | 1 |
Cases on record (4 of 4)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, West, Delhi | Civil suit | Filed against the company by Durga Polyplast Private Limited | Disposed |
| District court, Central, Delhi | Court case (L I R) | Filed against the company by an individual | Pending |
| High Court of Delhi | Writ petition | Filed by the company against an individual | Disposed |
| High Court of Delhi | Writ petition | Filed by the company against an individual | Disposed |
Full case history
All 4 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME Payment Delays by Abyss Pharma Private Limited
Abyss Pharma Private Limited has 2 MSME Form 1 returns on record for the period ending Mar 2019, listing 5 overdue payments to 3 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (3 of 3)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Premier Extrusions | •••• | •••• | •••• |
| an individual supplier | •••• | •••• | •••• |
| Indo Pack Limited | •••• | •••• | •••• |
Full MSME payment history
Every supplier, amount and due date from all 2 MSME Form 1 returns is in the company report.
- Every reported supplier due
- Amounts and due dates
- Reasons given in each return
- Period-by-period history
Verified entity values are shown only after access is granted.
Individuals and sole proprietors among the suppliers are not named. Amounts, due dates and filing dates are in the company report.
Associated Brands with Abyss Pharma Private Limited
Abyss Pharma operates one associated brand: Abyss Pharma. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Manufacturing and marketing of pharmaceutical formulations in India and international markets. | abysspharma.com |
Employees and EPFO Compliance at Abyss Pharma Private Limited
Abyss Pharma Private Limited has a workforce of 19 employees as of Feb 17, 2025.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Abyss Pharma Private Limited
Abyss Pharma Private Limited has 4 board changes on record since 1997: 2 appointments and 2 cessations. The latest: Neeraj Gupta ceased to be Director on 30 Nov 2022.
Credit Ratings, Litigation & Regulatory Alerts for Abyss Pharma Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Abyss Pharma Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Abyss Pharma Private Limited
Abyss Pharma has 2 GST registrations: 1 active and 1 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AABCA8551E2ZU | Delhi | Active | 25 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Abyss Pharma Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Abyss Pharma Private Limited
Abyss Pharma is an active private limited company based in New Delhi, Delhi, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 03 June 1997 (29+ years old) and is registered under CIN U24232DL1997PTC087663.
Abyss Pharma reported revenue of ₹19.15 Cr for FY 2024 (up 7% YoY).
Abyss Pharma has 2 current directors:
- Nitin Gupta - Director
- Vimal Kumar Gupta - Director
Abyss Pharma reported a net profit of ₹34.05 Lakh (net margin 1.8%) and EBITDA of ₹82.69 Lakh (EBITDA margin 4.3%) for FY 2024, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Abyss Pharma is 13% over three years and 30% over five years. In the latest year (FY 2024) revenue rose 7%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Abyss Pharma is 07AABCA8551E2ZU, registered in Delhi. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Abyss Pharma is U24232DL1997PTC087663. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Abyss Pharma has 4 court cases on record: 2 filed by the company and 2 filed against it. 1 is pending. Most are in the high courts.
Abyss Pharma was incorporated on 03 June 1997, making it 29+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Abyss Pharma by revenue are Curosis Healthcare Private Limited, Elkos Healthcare Private Limited, Invex Health Private Limited, Dr.Jrk's Research and Pharmaceuticals Private Limited, Elegant Cosmed Private Limited and 5 more, all in the Pharma industry (Formulations).
Neeraj Gupta ceased to be Director on 30 Nov 2022. Nitin Gupta was appointed as Director on 30 Nov 2022. Nitin Gupta ceased to be Director on 15 Jan 2021. Abyss Pharma has 4 board changes on record in total.
Abyss Pharma has 2 MSME Form 1 returns on record for the period ending Mar 2019, listing 5 overdue payments to 3 micro and small suppliers. The latest return was filed on 08 Jun 2019.